DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE - Generic Drug Details

What are the generic sources for dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate and what is the scope of freedom to operate?

Dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate is the generic ingredient in four branded drugs marketed by B Braun, Otsuka Icu Medcl, and Baxter Hlthcare, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

US Patents:	0
Tradenames:	4
Applicants:	3
NDAs:	4
Finished Product Suppliers / Packagers:	1
Clinical Trials:	30
DailyMed Link:	DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE at DailyMed

Recent Clinical Trials for DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mariam Hesham Mahmoud Abdelfattah Eissa	NA
Stefan Heber	EARLY_PHASE1
Turku University Hospital	PHASE3

See all DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE clinical trials

Pharmacology for DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Drug Class	Calculi Dissolution Agent Osmotic Laxative Potassium Salt
Mechanism of Action	Magnesium Ion Exchange Activity Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

Anatomical Therapeutic Chemical (ATC) Classes for DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

A12BA	Potassium
A12B	POTASSIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CC	Magnesium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	019843-001	Aug 9, 1993		DISCN	No	No
Baxter Hlthcare	PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017451-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
B Braun	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	018274-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Otsuka Icu Medcl	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017609-001	Approved Prior to Jan 1, 1982		RX	No	No

Market Dynamics and Financial Trajectory for Selected Pharmaceutical Salts

Last updated: February 16, 2026

---

What Are the Market Drivers for Dextrose, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, and Sodium Gluconate?

Global demand for these pharmaceutical and clinical-grade salts is driven by their critical roles in medical, nutritional, and industrial applications. Factors influencing market growth include rising incidences of dehydration, electrolyte imbalances, and chronic diseases requiring inpatient and outpatient care.

Key Drivers:

• Healthcare Expansion: Growing healthcare infrastructure particularly in emerging markets increases demand for intravenous fluids and electrolyte replenishment solutions.
• Aging Population: Age-related electrolyte imbalances elevate use in geriatrics.
• COVID-19 Impact: Increased hospitalization rates amplified needs for IV salts, especially sodium chloride and dextrose.
• Nutritional Supplements: Rising trend towards oral rehydration therapy and nutritional supplementation boosts sales of dextrose and sodium-based salts.
• Industrial Use: Use in pharmaceuticals, food preservatives, and chemical manufacturing sustains steady demand.

How Do Market Trends Vary Among the Salts?

Salt	Usage Domain	Growth Trends	Market Size (2023 est.)	Key Markets
Dextrose	IV therapy, nutritional supplements	Moderate growth; driven by hospital demand	~$1.2 billion	US, EU, China
Magnesium chloride	Electrolyte replenishment, muscle function	Steady growth; industrial use in magnesium extraction	~$600 million	Asia, North America
Potassium chloride	Electrolyte replenisher, medication	Consistent CAGR; vital in managing hypokalemia	~$1.0 billion	US, Europe, China
Sodium acetate	Buffer solutions, dialysis; food additive	Slight growth; niche applications	~$400 million	North America, EU
Sodium chloride	IV fluids, electrolyte balances	Large base; stable demand, slow growth in mature markets	~$4.5 billion	Global
Sodium gluconate	Water treatment, food industry, pharmaceuticals	Niche; growth dependent on industrial expansion	~$250 million	Asia, North America

What Are the Financial Shifts Expected in the Next Five Years?

Financial trajectories forecast moderate to strong growth, averaging a compound annual growth rate (CAGR) of 3-6% across this product segment.

Forecast Highlights (2023-2028):

• Market Growth: Total market expected to approach $9 billion by 2028, up from ~$7 billion in 2023.
• Segment Leaders: Sodium chloride dominates with over 50% market share; dextrose and potassium chloride follow as fast-growing segments.
• Geography: Asia-Pacific leads in growth, outperforming North America and Europe due to expanding healthcare systems and industrial capacities.
• Pricing Trends: Raw material prices particularly for bulk salts are stabilizing but susceptible to logistics and energy costs.
• Regulatory Impact: Stringent quality standards in pharmaceuticals favor established suppliers and OEMs with proven compliance.

Who Are the Key Players and Their Market Strategies?

• Fresenius Kabi: Focuses on high-quality injectable saline solutions, expanding capacity in Asia.
• Baxter International: Innovates in electrolyte management products, investing in supply chain resilience.
• Hikal Ltd.: Targets emerging markets with affordable bulk sodium salts for industrial and pharmaceutical use.
• Sigma-Aldrich (Merck): Offers broad portfolio of high-purity compounds, emphasizing R&D collaborations.
• Local Manufacturers: Strengthen regional supply chains due to cost pressures and regulatory hurdles.

---

What Are the Critical Challenges and Risks?

• Price Volatility: Raw material costs, notably natural salt sources and energy inputs, influence pricing.
• Regulatory Hurdles: Strict approvals can delay product launches or restrict market access, especially in US and EU.
• Supply Chain Disruptions: Pandemic-related logistics issues and geopolitical tensions threaten supply stability.
• Environmental Regulations: Increasing emphasis on sustainable production alter manufacturing standards and costs.

---

Key Takeaways

• Market for pharmaceutical salts is growing steadily, led by sodium chloride and dextrose.
• Asia-Pacific supplies the fastest growth, driven by healthcare expansion and industrialization.
• Price stability is challenged by raw material costs and regulatory compliance.
• Major companies invest in capacity, quality, and regional expansion to maintain competitive advantage.
• Supply chain resilience and adherence to evolving regulatory standards are critical for success.

---

FAQs

Q1: What is the primary driver for demand in sodium chloride?
Hospitals use sodium chloride in IV saline solutions, making it essential for electrolyte management in clinical settings globally.

Q2: How does manufacturing capacity affect market prices?
Increases in capacity generally lower prices, but supply constraints from raw material shortages or regulatory delays can cause price hikes.

Q3: Which geographic region is expected to lead growth?
Asia-Pacific is projected to lead due to expanding healthcare infrastructure and industrial use in countries like China and India.

Q4: Are regulatory standards affecting market entry?
Yes, stricter approvals in the US, EU, and other regions necessitate compliance with pharmacopoeias and quality certifications, impacting timelines and costs.

Q5: What is the outlook for industrial applications of these salts?
Industrial demand, especially for sodium gluconate, remains steady with emerging markets investing in water treatment and construction.

---

Sources

[1] MarketsandMarkets. "Electrolyte Solution Market," 2023.
[2] Grand View Research. "Pharmaceutical Salts Market Insights," 2023.
[3] Allied Market Research. "Global Sodium Chloride Market," 2023.
[4] ICIS. "Raw Material Pricing Trends," 2023.
[5] WHO. "Global Health and Aging," 2022.